DC
D. Ross Camidge is a researcher at the University of Colorado Anschutz Medical Campus. His work focuses on lung cancer, particularly targeted therapies for molecularly defined subsets such as ALK-positive and ROS1-positive non-small cell lung cancer, and he has been involved in clinical trials of tyrosine kinase inhibitors.
- Field
- Medicine · Oncology
- Clarivate categories
- Clinical Medicine
- Affiliation
- University of Colorado Anschutz Medical Campus, United States